Original Investigation

Vision Outcomes in Children Treated With Voretigene Neparvovec for -Associated Retinopathy

JAMA Ophthalmology 10.1001/jamaophthalmol.2025.5505

January 02, 2026 at 11:00 AM EST

Read the full article

What are the vision outcomes in young children with -associated retinopathy after voretigene neparvovec (VN) treatment?In this case series of 14 young children, VN gene therapy showed improvement of pattern visual evoked potentials (VEPs) in the majority of children, worsening in only in patients who showed localized chorioretinal atrophy.Results suggest that pattern VEPs objectively indicate functional recovery of the retinogeniculostriate pathway after VN treatment in young children with -associated retinopathy; these findings support the use of pattern VEPs as an outcome assessment in future pediatric retinal gene therapy trials, enhancing intertrial treatment evaluation and accelerating translation into practice.

Corresponding Author: Dorothy A. Thompson, PhD, Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street, London WC1N 3JH, United Kingdom (dorothy.thompson@ucl.ac.uk).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks